The following words and phrases when used in this chapter shall have the meanings given to them in this section unless the context clearly indicates otherwise:
"Controlled substance." As defined in the Act of April 14, 1972 ( P.L. 233, No.64), known as the Controlled Substance, Drug, Device and Cosmetic Act.
"Department." The Department of Health of the Commonwealth.
"Health care facility." A health care facility as defined in section 103 of the Act of July 19, 1979 ( P.L. 130, No.48), known as the Health Care Facilities Act, or any other facility or institution licensed, registered or otherwise permitted to distribute, dispense, conduct research with or prescribe or administer a controlled substance containing an opioid or other controlled substance in the course of professional practice or research in this Commonwealth.
"Licensing board." The term shall include the following:
"Opioid."Any of the following:
"Patient." An individual who is under the medical care of a practitioner.
"Practitioner." A health care practitioner as defined in section 103 of the Act of July 19, 1979 ( P.L. 130, No.48), known as the Health Care Facilities Act.
"Secretary." The Secretary of Health of the Commonwealth.
"System." The achieving better care by monitoring all prescriptions program electronic prescription monitoring system with a database component as established under the Act of October 27, 2014 ( P.L. 2911, No.191), known as the Achieving Better Care By Monitoring All Prescriptions Program (ABC-MAP) Act.
"Voluntary nonopioid directive." A written instruction form executed by a patient evidencing the named patient's request not to have a controlled substance containing an opioid offered, supplied, prescribed or otherwise administered to the named patient by a practitioner.
35 Pa.C.S. § 5202